Bodea, O.-M.; Mogoș, G.F.R.; Kundnani, N.R.; Sharma, A.; Adam, O.; Duda-Seiman, D.M.; Velimirovici, D.; Nicula-Neagu, M.; Bedreag, O.H.; Dragan, S.
Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center. Medicina 2026, 62, 256.
https://doi.org/10.3390/medicina62020256
AMA Style
Bodea O-M, Mogoș GFR, Kundnani NR, Sharma A, Adam O, Duda-Seiman DM, Velimirovici D, Nicula-Neagu M, Bedreag OH, Dragan S.
Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center. Medicina. 2026; 62(2):256.
https://doi.org/10.3390/medicina62020256
Chicago/Turabian Style
Bodea, Olivia-Maria, Gabriel Florin Răzvan Mogoș, Nilima Rajpal Kundnani, Abhinav Sharma, Ovidiu Adam, Daniel Marius Duda-Seiman, Dana Velimirovici, Marioara Nicula-Neagu, Ovidiu Horea Bedreag, and Simona Dragan.
2026. "Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center" Medicina 62, no. 2: 256.
https://doi.org/10.3390/medicina62020256
APA Style
Bodea, O.-M., Mogoș, G. F. R., Kundnani, N. R., Sharma, A., Adam, O., Duda-Seiman, D. M., Velimirovici, D., Nicula-Neagu, M., Bedreag, O. H., & Dragan, S.
(2026). Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center. Medicina, 62(2), 256.
https://doi.org/10.3390/medicina62020256
